Yahoo Finance • 2 months ago
Cathie Wood is always making moves. The co-founder, CEO, and investment manager of Ark Invest publishes daily transactions for her family of exchange-traded funds. We know what's she's selling. More importantly for this column's purposes,... Full story
Yahoo Finance • 5 months ago
Nvidia(NASDAQ: NVDA) is one of the most closely watched companies in the world. It was once primarily known as a top supplier of gaming GPUs for PCs, but it subsequently evolved into the dominant producer of high-end data center GPUs. Nvi... Full story
Yahoo Finance • 5 months ago
Shares of SoundHound AI(NASDAQ: SOUN) fell 21.8% in June 2024, according to data from S&P Global Market Intelligence. The voice control software specialist had no bad news to share last month, but investors shrugged off a handful of positi... Full story
Yahoo Finance • 6 months ago
Many famous names on Wall Street are rapidly scooping up shares of the most prominent artificial intelligence (AI) companies, including Nvidia and Alphabet, among other tech giants. Though these market leaders are attracting most of the AI... Full story
Yahoo Finance • 7 months ago
Nvidia(NASDAQ: NVDA) isn't just a leader in developing the key hardware fueling the artificial intelligence (AI) boom. It's a big investor in other AI companies, often including an equity investment in its business relationships. In Decemb... Full story
Yahoo Finance • 7 months ago
It's been a tough past three years for biotech stocks. Although the COVID-19 pandemic sparked bullish interest in the industry, this interest has waned since the contagion began winding down. Between late 2021 and now, the Nasdaq Biotechno... Full story
Yahoo Finance • 9 months ago
In this piece, we will take a look at the 13 best short squeeze stocks to buy now. If you want to skip our primer on short squeezing, and some of the greatest short squeezes in history, then you can take a look at the 5 Best Short Squeeze... Full story
Yahoo Finance • 9 months ago
Nvidia(NASDAQ: NVDA) announces its fourth-quarter and full-year 2023 results this week. It's likely to report full-year revenue in the ballpark of $60 billion. Roughly 45% of whatever revenue the chipmaker generates will roll to the bottom... Full story
Yahoo Finance • 9 months ago
Over any meaningful time span, Nvidia(NASDAQ: NVDA) has been a blockbuster investment. It's up almost 1,800% over the last five years, and it has more than tripled in the past year alone, fueled by investors' excitement for artificial inte... Full story
Yahoo Finance • 10 months ago
There never seems to be a bad time for Cathie Wood to reshape her portfolios. The founder, CEO, and main stock-picker for the Ark Invest family of exchange-traded funds has been busy adding to some of her positions this week. She has also... Full story
Yahoo Finance • 11 months ago
Cathie Wood kicked off the new trading year with three fresh purchases for her Ark Invest family of exchange-traded funds. All three stocks coincidentally begin with the letter "R" -- even though it wasn't a pirate-themed shopping spree.... Full story
Yahoo Finance • 11 months ago
In this article, we discuss the 11 most promising AI stocks according to hedge funds. To skip the detailed analysis of the AI industry, go directly to the 5 Most Promising AI Stocks According to Hedge Funds. Artificial intelligence (AI) w... Full story
Yahoo Finance • 11 months ago
innovation Investors have shown a lot of interest in thematic exchange-traded funds (ETFs) since 2019. These funds focus on specific themes or sectors expected to grow rapidly in the future. One of the prominent players in this space is A... Full story
Yahoo Finance • last year
Berlin, Germany and Salt Lake City, USA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that they h... Full story
Yahoo Finance • last year
SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced two significant updates with their collaborators NVID... Full story
Yahoo Finance • last year
Entered into a collaboration with Tempus giving Recursion access to over 20 petabytes of multimodal oncology data for the purpose of training causal AI models together with Recursion’s proprietary data and for designing biomarker and patie... Full story
Yahoo Finance • last year
SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conference... Full story
Yahoo Finance • last year
In this article, we discuss Duquesne Family Office's 15 new stock picks. If you want to see more stocks in this selection, check out Duquesne Family Office's 5 New Stock Picks. An imminent collapse and recession was the sentiment echoed b... Full story
Yahoo Finance • last year
SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferenc... Full story
Yahoo Finance • last year
SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has completed the Phase 1 study for REC-3964 in he... Full story